Stock Earnings

Question 1

What are Protagenic Therapeutics, Inc.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Diversified Healthcare Trust has a total asset of $4,361, Net loss of $-285

Question 2

What are the key financial ratios for PTIXW?

Accepted Answer

Diversified Healthcare Trust's Current ratio is 1.61, has a Net margin is -18.54, sales per share of $6.39.

Question 3

How is Protagenic Therapeutics, Inc.'s revenue broken down by segment or geography?

Accepted Answer

Diversified Healthcare Trust largest revenue segment is SHOP, at a revenue of 1,244,389,000 in the most earnings release.For geography, United States is the primary market for Diversified Healthcare Trust, at a revenue of 1,495,427,000.

Question 4

Is Protagenic Therapeutics, Inc. profitable?

Accepted Answer

no, according to the latest financial statements, Diversified Healthcare Trust has a net loss of $-285

Question 5

Does Protagenic Therapeutics, Inc. have any liabilities?

Accepted Answer

yes, Diversified Healthcare Trust has liability of 2,695

Question 6

How many outstanding shares for Protagenic Therapeutics, Inc.?

Accepted Answer

Diversified Healthcare Trust has a total outstanding shares of 242.12

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	1,537	1,537	1,495	1,410	1,283	1,383
Revenue Growth (YoY)	3%	3%	6%	10%	-7%	-15%
Cost of Revenue	1,259	1,259	1,236	1,174	1,109	1,091
Gross Profit	278	278	258	236	174	291
Selling, General & Admin	45	45	26	26	26	34
Research & Development	--	--	--	--	--	--
Operating Expenses	307	307	311	310	265	305
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-320	-320	-371	-272	-21	181
Income Tax Expense	1	1	0	0	0	1
Net Income	-285	-285	-370	-293	-15	174
Net Income Growth	-23%	-23%	26%	1,853%	-109%	-225%
Shares Outstanding (Diluted)	240.66	240.28	239.53	238.83	238.31	237.96
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	-1.18	-1.18	-1.54	-1.22	-0.06	0.73
EPS Growth	-23%	-23%	26%	1,757%	-109%	-224%
Free Cash Flow	-166	-166	-89	-224	-414	-290
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	18.08%	18.08%	17.25%	16.73%	13.56%	21.04%
Operating Margin	-1.82%	-1.82%	-3.47%	-5.24%	-7.09%	-0.93%
Profit Margin	-18.54%	-18.54%	-24.74%	-20.78%	-1.16%	12.58%
Free Cash Flow Margin	-10.8%	-10.8%	-5.95%	-15.88%	-32.26%	-20.96%
EBITDA	233	233	232	210	148	258
EBITDA Margin	15.15%	15.15%	15.51%	14.89%	11.53%	18.65%
D&A For EBITDA	261	261	284	284	239	271
EBIT	-28	-28	-52	-74	-91	-13
EBIT Margin	-1.82%	-1.82%	-3.47%	-5.24%	-7.09%	-0.93%
Effective Tax Rate	-0.31%	-0.31%	0%	0%	0%	0.55%

Protagenic Therapeutics, Inc. (PTIXW) Financial

PTIXW Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

PTIXW Income

Follow-Up Questions